Correlation Between Eliem Therapeutics and Oruka Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Oruka Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Oruka Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Oruka Therapeutics,, you can compare the effects of market volatilities on Eliem Therapeutics and Oruka Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Oruka Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Oruka Therapeutics,.

Diversification Opportunities for Eliem Therapeutics and Oruka Therapeutics,

0.22
  Correlation Coefficient

Modest diversification

The 3 months correlation between Eliem and Oruka is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Oruka Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oruka Therapeutics, and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Oruka Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oruka Therapeutics, has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Oruka Therapeutics, go up and down completely randomly.

Pair Corralation between Eliem Therapeutics and Oruka Therapeutics,

Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the Oruka Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Eliem Therapeutics is 1.08 times less risky than Oruka Therapeutics,. The stock trades about -0.12 of its potential returns per unit of risk. The Oruka Therapeutics, is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  2,407  in Oruka Therapeutics, on August 30, 2024 and sell it today you would lose (381.00) from holding Oruka Therapeutics, or give up 15.83% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy99.21%
ValuesDaily Returns

Eliem Therapeutics  vs.  Oruka Therapeutics,

 Performance 
       Timeline  
Eliem Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eliem Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Oruka Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oruka Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward-looking signals remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Eliem Therapeutics and Oruka Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eliem Therapeutics and Oruka Therapeutics,

The main advantage of trading using opposite Eliem Therapeutics and Oruka Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Oruka Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oruka Therapeutics, will offset losses from the drop in Oruka Therapeutics,'s long position.
The idea behind Eliem Therapeutics and Oruka Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
CEOs Directory
Screen CEOs from public companies around the world
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume